Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

Pregnancy Prediction in Non-sterile Patients After 4 Intrauterine Inseminations With Donor Using Anti-Müllerian Hormone

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06263192

Enrollment

342

Registered

2024-02-16

Start date

2020-10-01

Completion date

2023-05-01

Last updated

2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-Mullerian Hormone Deficiency, Infertility, Female

Keywords

anti-mullerian hormone, infertility, intrauterine insemination, sperm donation, cumulative pregnancy rates

Brief summary

The goal of this study is to compare the cumulative pregnancy rates after 4 artificial inseminations with donor (IAD) in non-sterile women with plasma AMH levels \> and \< 1.1 ng/mL.

Interventions

PROCEDUREIntrauterine insemination

Intrauterine insemination with sperm donors

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

25 Years to 39 Years

Inclusion criteria

* IUI cycles with sperm donors either due to severe oligoasthenoteratozoospermia in the partner (defined as a motile sperm count (MSC) \< 5 million in the ejaculate) or for social reasons, with up to 4 attempts accounted for.

Exclusion criteria

* BMI \>30 * Infertility due to bilateral tubal factor * Endometriosis grade II-IV.

Design outcomes

Primary

Measure	Time frame	Description
Cummulative pregnancy rate	36 months	Pregnancy rate after 4 cycles of IUI

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026